Florida Mammograms Now Flag Breast Artery Calcium
Women getting screening mammograms through MammoLink's mobile units can have breast arterial calcifications assessed from the same images.
Updated on Nov. 2, 2026 in Cancer
MammoLink, a physician-owned provider of mobile 3D mammography, has added CureMetrix's cmAngio to its breast imaging program. The FDA-cleared tool flags breast arterial calcifications from routine screening mammograms for patients across Florida.
Why it matters
Breast arterial calcifications are calcium deposits in the blood vessels of the breast that can be seen on mammograms, and this addition lets screening patients receive that information from the same exam. Because the analysis uses images already taken during standard screening, it may make this vascular information more routinely available to Florida women who get mammograms through mobile and community programs.
The source is a partnership announcement and does not include a clinical study design, sample size, or measured effect. The cmAngio software is described as FDA-cleared for detecting, quantifying and contextualizing breast arterial calcifications, but the announcement does not report performance results.
The players
MammoLink
A physician-owned provider of mobile 3D mammography services delivering screening to communities, employers and physician offices across Florida.
CureMetrix
A company that develops FDA-cleared software, including cmAngio, for detecting breast arterial calcifications on routine mammograms.
The details
cmAngio is an FDA-cleared software solution that detects, quantifies and contextualizes breast arterial calcifications from the screening mammogram itself. It requires no additional imaging, radiation, procedures or changes to standard mammography workflows. MammoLink integrates it into its mobile 3D mammography services, which travel to communities, employers and physician offices across Florida.
Health Landscape
Breast arterial calcifications have been studied as a marker visible on standard mammograms, and cmAngio is a software tool designed to surface them without extra imaging. Adding it to mobile screening programs expands how this information can reach patients outside traditional imaging centers.
If you are due for a screening mammogram in Florida, ask whether your provider uses software such as cmAngio that reviews the images for breast arterial calcifications. Findings like these are worth discussing with your doctor, who can explain what they may mean for your heart and overall health.
The takeaway
A routine mammogram may now reveal more than breast tissue alone, and breast arterial calcifications can be a useful conversation point with your physician. Ask your screening provider whether this analysis is available at your next appointment.
Further reading
For more on how breast cancer screening is evolving, explore our Cancer coverage.
Source note: This article includes information reported by Scientist Live.
